Autonomous surgical robots with initial focus on urologyYC S23

Y Combinator alumni venture fundMost active seed investor in the world as per Pitchbook

Co-invented implantable device for BPH (enlarged prostate) and led company through market readiness.Product has successfully treated > 300 patients in six countries.Raised > $60M in venture, angel, debt, and grant funding.Hired and led elite team of 28 FTEs.First medtech company funded by Y Combinator (YC W15).Outexecuted all competitors in a crowded space and left company in prime position for successful pivotal trial completion and commercial launch.

A new & more powerful adult pluripotent stem cell platform for hard-to-treat diseases

Company was acquired by MendaeraFormerly known as Nurep

Initially known as Nurep, Inc. Telepresence for the operating room. Launched in ~1000 medical facilities. Our goal was to change the outdated system where surgeons could only get expert support from someone physically in the OR.In 2012, nobody believed we could overcome the massive opposition to this paradigm shift.Mission accomplished and it's now the industry standard.

Went to Delhi to help a medtech company based there with global commercialization strategy

World's leading innovation program for medtech

Blueprint Health is a Charter Member of the Global Accelerator Network, which was started by TechStars

Developed key algorithms for world's first fully functional leadless pacemakerASX: EBR